Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.
Amgen sees highest filings and grants during July in Q3 2023
Share this article Amgen has been focused on protecting inventions in European Patent Office (E/P) with 91 publications in Q3 2023 The European Patent Office